1. Home
  2. News Archive

More News

€1 Million Champalimaud Vision Award in 2026 Goes to Botond Roska and José-Alain Sahel
€1 Million Champalimaud Vision Award in 2026 Goes to Botond Roska and José-Alain Sahel

The winners of the 2026 António Champalimaud Vision Award are researchers Botond Roska, MD, PhD, of Switzerland, and José-Alain Sahel, MD, of France and the US, for their pioneering optogenetic the...

Norlase Establishes Direct Commercial Presence in the United Kingdom
Norlase Establishes Direct Commercial Presence in the United Kingdom

Norlase announced on Sept. 8 that it had expanded its footprint in Europe with a direct commercial presence in the United Kingdom. The Danish company, with US offices in Redwood City, California, a...

Chinese Regulators Accept NDA for Low-Dose Atropine Drop for Myopia from Santen
Chinese Regulators Accept NDA for Low-Dose Atropine Drop for Myopia from Santen

Japan’s Santen announced Sept. 14 that China’s National Medical Products Administration (NMPA) had accepted the new drug application (NDA) for STN1012700 (atropine sulfate ophthalmic solution 0.025...

Ophthalmologists Report 5.4 Percent Decrease in Q2-2026 Procedure Volume
Ophthalmologists Report 5.4 Percent Decrease in Q2-2026 Procedure Volume

US ophthalmologists reported that ophthalmic procedures decreased 5.4 percent in Q2-2026 compared with the same quarter in 2025, according to Market Scope’s latest survey. Year-over-year performanc...

Ophthalmic Company Revenue Drops 0.8 Percent in Second Quarter of 2026
Ophthalmic Company Revenue Drops 0.8 Percent in Second Quarter of 2026

Ophthalmic manufacturer revenue in Q2-2026 totaled $11.8 billion. Revenue decreased 0.8 percent from the same quarter in 2025 and increased 3.3 percent from Q1-2026. The total includes Market Scope...

New IRD Therapies Could Shake Up Nonexudative Retinal Pharma Market
New IRD Therapies Could Shake Up Nonexudative Retinal Pharma Market

Complement inhibitors reaped more than three-quarters of manufacturers’ revenue in the nonexudative retinal pharmaceuticals market in 2025, but candidates for inherited retinal diseases (IRD) are g...

Ophthalmologist Urges Early Intervention in Dry Eye Management to Avoid Surprises
Ophthalmologist Urges Early Intervention in Dry Eye Management to Avoid Surprises

Jason Bacharach, MD, of North Bay Eye Associates in northern California, has a word of advice for ophthalmologists and optometrists. Four words, actually: interventional dry eye management (IDEM). ...

Alcon Launches Unity M Ophthalmic Surgical Microscope
Alcon Launches Unity M Ophthalmic Surgical Microscope

Alcon announced Sept. 3 the initial commercial launch of its Unity M ophthalmic surgical microscope. The company said the microscope, which has received CE marking in Europe and regulatory approval...

Select US FDA Approvals and Clearances in August 2026
Select US FDA Approvals and Clearances in August 2026

The US FDA’s ophthalmic device division granted clearance to three devices using the 510(k) pathway in August 2026, according to the agency’s database. Sight Sciences received clearance for a label...

PDUFA Dates for Ophthalmic Drug Candidates, September 2026
PDUFA Dates for Ophthalmic Drug Candidates, September 2026

The US FDA has scheduled the following Prescription Drug User Fee Act (PDUFA) and Biosimilar User Fee Act (BsUFA) target action dates for ophthalmic drug, drug/device, and biologic candidates.

Bausch + Lomb Gains CE Marking for SeeLyra Femtosecond Laser
Bausch + Lomb Gains CE Marking for SeeLyra Femtosecond Laser

Bausch + Lomb reported Sept. 11 that its SeeLyra next-generation femtosecond laser had gained CE marking. The company said the SeeLyra, built on the Victus platform, is designed to provides surgeon...

EyePoint’s Duravyu Misses Primary Visual Acuity Endpoint in Phase III Wet AMD Trial
EyePoint’s Duravyu Misses Primary Visual Acuity Endpoint in Phase III Wet AMD Trial

EyePoint Pharmaceuticals reported Aug. 17 that Duravyu (vorolanib intravitreal insert) missed its primary visual acuity endpoint in topline results from the Phase III LUGANO trial in wet age-relate...

Balance Announces 2026 Medicare Pricing for FSYX Pump and Goggles
Balance Announces 2026 Medicare Pricing for FSYX Pump and Goggles

Balance Ophthalmics reported Aug. 18 that regulators had set 2026 Medicare payment amounts for the FSYX Ocular Pressure Adjusting Pump (OPAP) and associated goggles, effective Oct. 1. The FSYX pump...

UK Government Outlines Measures to Reduce Ophthalmology Waiting Times
UK Government Outlines Measures to Reduce Ophthalmology Waiting Times

The UK government on Aug. 25 outlined initiatives intended to reduce ophthalmology waiting times, address regional disparities, and move more eye care into community and digital settings. Gillian J...

Oxford Eye Hospital Initiative Cuts IVT Injection Waste and Costs
Oxford Eye Hospital Initiative Cuts IVT Injection Waste and Costs

Britain’s Oxford Eye Hospital reported Aug. 24 that an initiative there to change the way intravitreal (IVT) injections are administered has eliminated tons of associated single-use product waste a...

Ingenia Leads Latest Fundraising with $42.3 Million Initial Public Offering
Ingenia Leads Latest Fundraising with $42.3 Million Initial Public Offering

Ingenia Therapeutics led recent ophthalmic fundraising efforts, which totaled $57.3 million in the past four weeks.

Clinical Trial Updates for Ophthalmic Candidates, September 2026
Clinical Trial Updates for Ophthalmic Candidates, September 2026

Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.

Bausch + Lomb Advancing Dual-Action Dry Eye Drop, Ocular Surface Pain Candidate
Bausch + Lomb Advancing Dual-Action Dry Eye Drop, Ocular Surface Pain Candidate

Bausch + Lomb reported Aug. 24 that it would advance two of its topical ocular pipeline candidates based on clinical trial results. The company’s dual-action dry eye drop candidate—combining lifite...

Indigo Light Prevents Myopia in Animal Model, Researchers Find
Indigo Light Prevents Myopia in Animal Model, Researchers Find

Vision researchers have found that indigo light prevents myopia completely in a tree shrew model. Their findings were published Aug. 18, 2026, in Cell Reports Medicine. The study’s lead researchers...

Lumibird Medical Launches Astral Contactless SLT Platform with Integrated OCT
Lumibird Medical Launches Astral Contactless SLT Platform with Integrated OCT

France’s Lumibird Medical announced Sept. 12 the launch of the Astral, a contactless selective laser trabeculoplasty (SLT) platform for glaucoma. The device was unveiled at the 2026 European Societ...

2026-2027 Ophthalmic Meetings Calendar
2026-2027 Ophthalmic Meetings Calendar

Market Scope regularly updates its list of ophthalmic meetings to keep the information current. Please contact us at matthewdouty@market-scope.com if we do not have your meeting listed. Thank you.

Emerging Companies Pursuing Ophthalmic Indications, September 2026
Emerging Companies Pursuing Ophthalmic Indications, September 2026

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

European Consortium Studies Gene-Silencing Eye Drops Targeting Corneal Vascularization
European Consortium Studies Gene-Silencing Eye Drops Targeting Corneal Vascularization

Two studies underway at the University of Cologne in Germany will test whether a new class of eye drops silencing the insulin-receptor substrate 1 (IRS1) gene can slow the blood vessel growth that ...

Weekly Poll of MDs, US and Western Europe, September 2026
Weekly Poll of MDs, US and Western Europe, September 2026

September 2026 Ophthalmic News Briefs
September 2026 Ophthalmic News Briefs

UK-based Rayner reported Sept. 7 the launch of its Galaxy Hydrophobic spiral IOL. The lens will be available commercially in the EU in Q4-2026. The original Galaxy spiral IOL, a full range of visio...

Lumibird Medical Launches Astral Contactless SLT Platform with Integrated OCT
Lumibird Medical Launches Astral Contactless SLT Platform with Integrated OCT

France’s Lumibird Medical announced Sept. 12 the launch of the Astral, a contactless selective laser trabeculoplasty (SLT) platform for glaucoma. The device was unveiled at the 2026 congress of the...

Balance Ophthalmics Announces 2026 Medicare Pricing for FSYX Pump and Goggles
Balance Ophthalmics Announces 2026 Medicare Pricing for FSYX Pump and Goggles

Balance Ophthalmics reported Aug. 18 that regulators had set 2026 Medicare payment amounts for the FSYX Ocular Pressure Adjusting Pump (OPAP) and associated goggles, effective Oct. 1. The FSYX pump...

US FDA Gives Green Light to Trial of Ciliatech’s Intercil Uveal Spacer for Glaucoma
US FDA Gives Green Light to Trial of Ciliatech’s Intercil Uveal Spacer for Glaucoma

France’s Ciliatech announced Sept. 8 that the US FDA had signed off on its investigational device exemption (IDE) submission, allowing the company to proceed with a feasibility study of its Interci...

US FDA Accepts BLA for Nanoscope’s Optogenetic Gene Therapy Candidate in RP
US FDA Accepts BLA for Nanoscope’s Optogenetic Gene Therapy Candidate in RP

Nanoscope Therapeutics announced Sept. 9 that the US FDA had accepted for review its biologics license application (BLA) for Mogenry, an optogenetic gene therapy candidate designed to restore visio...

Surrozen Submits IND Application for Dual-Acting SZN-8141 in DME
Surrozen Submits IND Application for Dual-Acting SZN-8141 in DME

Surrozen announced Sept. 8 that it had submitted an investigational new drug (IND) application to the US FDA to launch a clinical trial of SZN-8141, a bifunctional Wnt agonist and vascular endothel...

Chinese Regulators Accept NDA for Glaucoma Drop from Nicox, Ocumension
Chinese Regulators Accept NDA for Glaucoma Drop from Nicox, Ocumension

France’s Nicox and partner Ocumension Therapeutics, of China, announced Sept. 11 that China’s National Medical Products Administration (NMPA) had accepted the new drug application (NDA) for NCX 470...

Belite Bio Submits NDA in Japan for Oral Tinlarebant in Stargardt
Belite Bio Submits NDA in Japan for Oral Tinlarebant in Stargardt

Belite Bio announced Sept. 8 that it had submitted a new drug application (NDA) for its oral Stargardt treatment candidate, tinlarebant, to Japan’s Ministry of Health, Labour, and Welfare. Tinlareb...

Foundation Fighting Blindness Renames Venture Arm as Gund Vision Fund
Foundation Fighting Blindness Renames Venture Arm as Gund Vision Fund

The Foundation Fighting Blindness, of Columbia, Maryland, reported Sept. 10 that it had renamed its venture philanthropy arm the Gund Vision Fund. The fund was formerly called the Retinal Degenerat...

Bausch + Lomb Gains CE Marking for SeeLyra Femtosecond Laser
Bausch + Lomb Gains CE Marking for SeeLyra Femtosecond Laser

Bausch + Lomb reported Sept. 11 that its SeeLyra next-generation femtosecond laser had gained CE marking. The company said the SeeLyra, built on the Victus platform, is designed to provides surgeon...

Rayner Launches Galaxy Hydrophobic Spiral IOL
Rayner Launches Galaxy Hydrophobic Spiral IOL

UK-based Rayner reported Sept. 7 the launch of its Galaxy Hydrophobic spiral IOL at the 2026 ESCRS congress in London. The lens will be available commercially in the EU in Q4-2026. The original Gal...

Zeiss Announces Launch of AT Lucia Toric 721P
Zeiss Announces Launch of AT Lucia Toric 721P

Zeiss Medical Technology reported Sept. 10 that it was launching its AT Lucia Toric 721P IOL at the 2026 ESCRS congress in London. Zeiss, of Germany, described the lens as the world's first hyd...

Oxford Eye Hospital Initiative Cuts IVT Injection Waste and Costs
Oxford Eye Hospital Initiative Cuts IVT Injection Waste and Costs

Britain’s Oxford Eye Hospital reported Aug. 24 that an initiative there to change the way intravitreal (IVT) injections are administered has eliminated tons of associated single-use product waste a...

Alcon’s Clareon Monofocal Lens Gains MDR Certification, Expanded Labeling
Alcon’s Clareon Monofocal Lens Gains MDR Certification, Expanded Labeling

Alcon reported Sept. 1 that it had gained MDR certification in the European Union for its Clareon Monofocal enhanced monofocal intraocular lens. The company noted that the hydrophobic acrylic lens ...

UK Government Outlines Measures to Reduce Ophthalmology Waiting Times
UK Government Outlines Measures to Reduce Ophthalmology Waiting Times

The UK government on Aug. 25 outlined initiatives intended to reduce ophthalmology waiting times, address regional disparities, and move more eye care into community and digital settings. Gillian J...

British Company Exonate Rebrands as Foventa Therapeutics
British Company Exonate Rebrands as Foventa Therapeutics

British company Exonate announced Sept. 1 that it had changed its name to Foventa Therapeutics. The company said its new name and motto “Simply Sharper” take inspiration from the fovea, the center ...

European Consortium Studies Gene-Silencing Eye Drops Targeting Corneal Vascularization
European Consortium Studies Gene-Silencing Eye Drops Targeting Corneal Vascularization

Two studies underway at the University of Cologne in Germany will test whether a new class of eye drops silencing the insulin-receptor substrate 1 (IRS1) gene can slow the blood vessel growth that ...

Stem Cell Treatment Improves Vision for Aniridia-Related Keratopathy
Stem Cell Treatment Improves Vision for Aniridia-Related Keratopathy

Researchers at Moorfields Eye Hospital and the University College of London have developed a collagen scaffold that delivers limbal epithelial and stromal stem cells to improve vision in eyes with ...

University of Virginia Team Uses Nanotechnology to ID New Target for Treating Glaucoma
University of Virginia Team Uses Nanotechnology to ID New Target for Treating Glaucoma

Researchers at the University of Virginia have used cutting-edge nanotechnology to probe Schlemm’s canal and identify a potential new genetic target to regulate aqueous humor drainage in patients w...

Alcon Launches Unity M Ophthalmic Surgical Microscope
Alcon Launches Unity M Ophthalmic Surgical Microscope

Alcon announced Sept. 3 the initial commercial launch of its Unity M ophthalmic surgical microscope. The company said the microscope, which has received CE marking in Europe and regulatory approval...

X-Cel and Essilor Launch Lunara Orthokeratology Lens
X-Cel and Essilor Launch Lunara Orthokeratology Lens

X-Cel Specialty Contacts and Essilor Custom Contacts announced Aug. 31 the US launch of Lunara, a new FDA-approved orthokeratology lens. Orthokeratology, or ortho-k, uses specially designed and fit...

AI Replaces Presurgical Scans in Removal of Sight-Threatening Brain Tumor
AI Replaces Presurgical Scans in Removal of Sight-Threatening Brain Tumor

The European Medical Journal reported Aug. 28 that artificial intelligence had provided real-time guidance for removal of a vision-threatening brain tumor at University College London Hospital (UCL...

SpyGlass Celebrates Grand Opening of New Irvine, California, Headquarters
SpyGlass Celebrates Grand Opening of New Irvine, California, Headquarters

SpyGlass Pharma celebrated the grand opening of its new Irvine, California, headquarters on Aug. 27, as the company continues to expand. SpyGlass was initially founded in Irvine in 2019 by Malik Y....

Ophthalmologist Urges Early Intervention in Dry Eye Management to Avoid Surprises
Ophthalmologist Urges Early Intervention in Dry Eye Management to Avoid Surprises

Jason Bacharach, MD, of North Bay Eye Associates in northern California, has a word of advice for ophthalmologists and optometrists. Four words, actually: interventional dry eye management (IDEM). ...

Basketball Topped US Sports Eye Injuries Treated in 2025, Statistics Show
Basketball Topped US Sports Eye Injuries Treated in 2025, Statistics Show

Basketball had the highest rate of sports-related eye injuries treated in the US in 2025, with 5,236 injuries, according to new statistics published Aug. 26 by Prevent Blindness. The Chicago, Illin...

US FDA Asks for Feedback on GenAI Medical Device Regulation
US FDA Asks for Feedback on GenAI Medical Device Regulation

The US FDA took inspiration from the way human clinicians are trained in drafting a proposal for the regulation of medical devices that feature generative artificial intelligence (GenAI), and it’s ...

Want to Read Locked Articles?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more